Press release
Head and Neck Cancer Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | CEL-SCI, Coherus, Exelixis, Immutep, Merck, Iovance Biotherapeutics, BeiGene, Akeso, Kura Oncology, Roche, Eli Lilly
"Head and Neck Cancer (HNC) Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Head and Neck Cancer Therapeutics Market.
The report provides a detailed description of the Head and Neck Cancer drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Head and Neck Cancer Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/head-and-neck-cancer-hnc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Head and Neck Cancer (HNC) Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Head and Neck Cancer therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Head and Neck Cancer treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Head and Neck Cancer drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreements, and financing details for future advancement in the Head and Neck Cancer treatment market.
Learn More about the Clinical and Commercial Development Activities in the Head and Neck Cancer Therapeutics Domain:
https://www.delveinsight.com/report-store/head-and-neck-cancer-hnc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Head and Neck Cancer Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Route of Administration
Head and Neck cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Inhalation
• Inhalation/Intravenous/Oral
• Intranasal
• Intravenous
• Intravenous/ Subcutaneous
• Oral
• Oral/intranasal/subcutaneous
• Parenteral
• Subcutaneous
Molecule Type
Products have been categorized under various Molecule types such as
• Antibody
• Antisense oligonucleotides
• Immunotherapy
• Monoclonal antibody
• Peptides
• Protein
• Recombinant protein
• Small molecule
• Stem Cell
• Vaccine
Request for Sample PDF to Understand More About the Head and Neck Cancer Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/sample-request/head-and-neck-cancer-hnc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Head and Neck Cancer (HNC) Therapeutics Analysis
There are approx. 150+ key companies developing therapies for Head and Neck cancer. Currently, Innate Pharma is leading the therapeutics market with its Head and Neck cancer drug candidates in the most advanced stage of clinical development.
Head and Neck Cancer (HNC) Companies Active in the Therapeutics Market Include
CEL-SCI, Junshi Biosciences, Coherus, Exelixis, Immutep S.A.S., Merck Sharp & Dohme LLC, Iovance Biotherapeutics, BeiGene, Akeso, Chia Tai-Tianqing, Kura Oncology, Hoffmann-La Roche, Eli Lilly and Company, and many others.
Emerging and Marketed Head and Neck Cancer Therapies Covered in the Report Include
• Enoblituzumab: MacroGenics
• KEYTRUDA (pembrolizumab): Merck Sharp & Dohme
• Monalizumab: Innate Pharma
• Niraparib: GlaxoSmithKline
• TECENTRIQ (Atezolizumab): Hoffmann-La Roche
• Tipifarnib: Kura Oncology
• Toripalimab: Junshi Biosciences/Coherus
• XEVINAPANT (debio 1143): Merck KGaA
• Xevinapant: Debiopharm
And Many More
Get an in-depth Assessment of the Emerging Therapies and Head and Neck Cancer Companies Actively Working in the Market:
https://www.delveinsight.com/sample-request/head-and-neck-cancer-hnc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Head and Neck Cancer Current Treatment Patterns
4. Head and Neck Cancer - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Head and Neck Cancer Late-Stage Products (Phase-III)
7. Head and Neck Cancer Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Head and Neck Cancer Discontinued Products
13. Head and Neck Cancer Product Profiles
14. Head and Neck Cancer Companies
15. Head and Neck Cancer Drugs
16. Dormant and Discontinued Products
17. Head and Neck Cancer Unmet Needs
18. Head and Neck Cancer Future Perspectives
19. Head and Neck Cancer Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/head-and-neck-cancer-hnc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight
Preeclampsia Market
https://www.delveinsight.com/report-store/preeclampsia-market
Chronic Periodontitis Market
https://www.delveinsight.com/report-store/chronic-periodontitis-market
Cryptococcosis Market
https://www.delveinsight.com/report-store/cryptococcosis-market
Exocrine Pancreatic Insufficiency Market
https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-market
Papilloma MarketRespiratory Distress Syndrome Market
https://www.delveinsight.com/report-store/respiratory-distress-syndrome-market
Sinusitis Market
https://www.delveinsight.com/report-store/sinusitis-market
Childhood Atropine For Myopia Progression Market
https://www.delveinsight.com/report-store/childhood-atropine-for-myopia-progression-market
Cushing's Syndrome Market
https://www.delveinsight.com/report-store/cushings-syndrome-market
Skin Burns Market
https://www.delveinsight.com/report-store/skin-burns-market
Adeno-Associated Virus Vectors in Gene Therapy Market
https://www.delveinsight.com/report-store/adeno-associated-virus-vectors-in-gene-therapy-market
Autism Spectrum Disorder Market
https://www.delveinsight.com/report-store/autism-spectrum-disorder-asd-market
Fragile X Syndrome (FXS) Market
https://www.delveinsight.com/report-store/fragile-x-syndrome-fxs-market
Lymphedema Market
https://www.delveinsight.com/report-store/lymphedema-market
Optic Neuropathy Market
https://www.delveinsight.com/report-store/optic-neuropathy-market
Nicotine Addiction MarketDiverticulitis Market
https://www.delveinsight.com/report-store/diverticulitis-market
Sinus Dilation Devices Market
https://www.delveinsight.com/report-store/sinus-dilation-devices-market
Von Willebrand disease (VWD) Market
https://www.delveinsight.com/report-store/von-willebrand-disease-vwd-market
Type 2 Diabetes Market
https://www.delveinsight.com/report-store/type-2-diabetes-market
Bone Resorption Market
https://www.delveinsight.com/report-store/bone-resorption-market
Peptic Ulcers Market
https://www.delveinsight.com/report-store/peptic-ulcers-market
Castration-Resistant Prostate Cancer (CRPC) Market
https://www.delveinsight.com/report-store/castration-resistant-prostate-cancer-crpc-market
Dysmenorrhea Market
https://www.delveinsight.com/report-store/dysmenorrhea-market
HDAC Inhibitors Market
https://www.delveinsight.com/report-store/hdac-inhibitors-market
Iron Deficiency Anemia Market
https://www.delveinsight.com/report-store/iron-deficiency-anemia-market
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market
https://www.delveinsight.com/report-store/chronic-inflammatory-demyelinating-polyneuropathy-cidp-market
Myelodysplastic Syndrome Market
https://www.delveinsight.com/report-store/myelodysplastic-syndrome-market
Sacral Nerve Stimulator Devices Market
https://www.delveinsight.com/report-store/sacral-nerve-stimulator-devices-market
Graft Versus Host Disease Market
https://www.delveinsight.com/report-store/graft-versus-host-disease-gvhd-market
Traumatic Brain Injury Market
https://www.delveinsight.com/report-store/traumatic-brain-injury-market
Artificial Disc Market
https://www.delveinsight.com/report-store/artificial-disc-market
Corneal Endothelial Dystrophy Market
https://www.delveinsight.com/report-store/corneal-endothelial-dystrophy-market
Bone Neoplasms Market
https://www.delveinsight.com/report-store/bone-neoplasms-market
Duchenne Muscular Dystrophy Market
https://www.delveinsight.com/report-store/duchenne-muscular-dystrophy-market
Secondary Hyperparathyroidism Market
https://www.delveinsight.com/report-store/secondary-hyperparathyroidism-market
Fetal Monitoring Devices Market
https://www.delveinsight.com/report-store/fetal-monitoring-devices-market
Relapsing Multiple Sclerosis (RMS) Market
https://www.delveinsight.com/report-store/relapsing-multiple-sclerosis-rms-market
Interspinous Spacers Market
https://www.delveinsight.com/report-store/interspinous-spacers-market
Cerebral Palsy Market
https://www.delveinsight.com/report-store/cerebral-palsy-market
Glioblastoma Market
https://www.delveinsight.com/report-store/glioblastoma-market
Breast Pumps Market
https://www.delveinsight.com/report-store/breast-pumps-market
Diabetic Peripheral Neuropathy Market
https://www.delveinsight.com/report-store/diabetic-peripheral-neuropathy-market
Throat Cancer Market
https://www.delveinsight.com/report-store/throat-cancer-market
Osteoporosis Market
https://www.delveinsight.com/report-store/osteoporosis-market
Implantable Cardioverter Defibrillators (ICDs) Market
https://www.delveinsight.com/report-store/implantable-cardioverter-defibrillators-icds-market
Open-Angle Glaucoma Market
https://www.delveinsight.com/report-store/open-angle-glaucoma-market
Atopic Dermatitis Market
https://www.delveinsight.com/report-store/atopic-dermatitis-market
Prurigo Nodularis Market
https://www.delveinsight.com/report-store/prurigo-nodularis-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Head and Neck Cancer Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | CEL-SCI, Coherus, Exelixis, Immutep, Merck, Iovance Biotherapeutics, BeiGene, Akeso, Kura Oncology, Roche, Eli Lilly here
News-ID: 3166573 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Head
Green Dot Sign® Going Head-to-Head with Traditional Plastic ADA Signs
After the success of their groundbreaking sustainable ADA compliant interior signs, Green Dot Sign® is now offering a more affordable and adaptable option than ever before: Low profile office signs.
Nussbaum started considering environmentally-friendly manufacturing methods and products while working at his prior sign company. The idea to create signage from a wood base and non-toxic 3D printed material for lettering, braille, and pictograms was sparked by a braille sign with…
China and India are growing head to head in Companion Diagnostic market
“Asia-Pacific Companion Diagnostics Market" research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 27.91% to reach USD 2.17 billion by 2021, from USD 0.63 billion in 2016, which amounts to a cumulative growth of USD 1.54 billion.
A companion diagnostics device is a medical device that provides information which is necessary for drug safety and effectives or any other biological product. This helps…
East and West going head to head in Asia-Pacific Food Emulsifiers Market
Asia-Pacific Food Emulsifiers Market" research report, published by Market Data Forecast delineates that the market is growing with a CAGR of 6.15% to reach USD 0.78 billion by 2021, from USD 0.58 billion in 2016, which amounts to a cumulative growth of USD 0.20 billion.
View Full Report at http://www.marketdataforecast.com/market-reports/asia-pacific-food-emulsifiers-market-564/
Download Free Sample report at http://www.marketdataforecast.com/market-reports/asia-pacific-food-emulsifiers-market-564/request-sample
A substance used in food manufacturing which helps to combine liquids of different thicknesses is known as…
dinCloud Earns Top Marks in Head-to-Head Comparison
The #1 Brand in Hosted Virtual Desktops
LOS ANGELES, CA – June 19, 2012 – dinCloud, a cloud transformation company and provider of hosted virtual desktops, has come out on top as the leading provider of DaaS (Desktop as a Service) in a head-to-head comparison of five market leaders by ExtremeLabs. dinCloud’s solution received the groupings highest marks for the solution’s good control, as well as fast response, and was the…
University Students go head to head in University of Bolton’s “Sports Fiesta …
The University of Bolton Student’s Council and the Student Activities Department organized an integrated program of sporting activities around the theme "Sports Fiesta 2012" which drew a number of Universities from the Northern Emirates and Dubai.
The activities took place at UOB RAK Campus. Separate activities for male and female attendees included; badminton, basketball, chess, cricket, darts, tug-o-war, sprint race, football and volleyball matches, and other recreational games.
To coincide with the…
KnowledgetoAction Departments Go Head to Head in a Bowling Competition
London, UK ( ) October 25, 2010 - Employees of KnowledgetoAction (http://knowledgeandaction.co.uk) have been going head to head against each other in a series of team building competitions that began on September 1, 2010. Knowledge to Action believes strongly in team building and this event showcased their desire for excellent team cooperation and communication between departments, allowing for more cohesiveness within Knowledge to Action.
Most recently, each of the KnowledgetoAction…
